Carrie L. Walters, Ph.D. - Publications

Affiliations: 
2004 University of Pennsylvania, Philadelphia, PA, United States 
Area:
addiction, depression, transcription factor

13 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Jackson KJ, Muldoon PP, Walters C, Damaj MI. Neuronal calcium/calmodulin-dependent protein kinase II mediates nicotine reward in the conditioned place preference test in mice. Behavioural Pharmacology. PMID 26292186 DOI: 10.1097/Fbp.0000000000000189  0.398
2009 Jackson KJ, Walters CL, Miles MF, Martin BR, Damaj MI. Characterization of pharmacological and behavioral differences to nicotine in C57Bl/6 and DBA/2 mice. Neuropharmacology. 57: 347-55. PMID 19619563 DOI: 10.1016/J.Neuropharm.2009.07.020  0.372
2009 Jackson KJ, Walters CL, Damaj MI. Beta 2 subunit-containing nicotinic receptors mediate acute nicotine-induced activation of calcium/calmodulin-dependent protein kinase II-dependent pathways in vivo. The Journal of Pharmacology and Experimental Therapeutics. 330: 541-9. PMID 19435931 DOI: 10.1124/Jpet.109.153171  0.306
2008 Merritt LL, Martin BR, Walters C, Lichtman AH, Damaj MI. The endogenous cannabinoid system modulates nicotine reward and dependence. The Journal of Pharmacology and Experimental Therapeutics. 326: 483-92. PMID 18451315 DOI: 10.1124/Jpet.108.138321  0.379
2006 Walters CL, Brown S, Changeux JP, Martin B, Damaj MI. The beta2 but not alpha7 subunit of the nicotinic acetylcholine receptor is required for nicotine-conditioned place preference in mice. Psychopharmacology. 184: 339-44. PMID 16416156 DOI: 10.1007/S00213-005-0295-X  0.318
2005 Walters CL, Cleck JN, Kuo YC, Blendy JA. Mu-opioid receptor and CREB activation are required for nicotine reward. Neuron. 46: 933-43. PMID 15953421 DOI: 10.1016/J.Neuron.2005.05.005  0.587
2005 Blendy JA, Strasser A, Walters CL, Perkins KA, Patterson F, Berkowitz R, Lerman C. Reduced nicotine reward in obesity: cross-comparison in human and mouse. Psychopharmacology. 180: 306-15. PMID 15719224 DOI: 10.1007/S00213-005-2167-9  0.519
2005 Walters CL, Godfrey M, Li X, Blendy JA. Alterations in morphine-induced reward, locomotor activity, and thermoregulation in CREB-deficient mice. Brain Research. 1032: 193-9. PMID 15680959 DOI: 10.1016/J.Brainres.2004.11.013  0.613
2003 Walters CL, Kuo YC, Blendy JA. Differential distribution of CREB in the mesolimbic dopamine reward pathway. Journal of Neurochemistry. 87: 1237-44. PMID 14622103 DOI: 10.1046/J.1471-4159.2003.02090.X  0.586
2003 Walters CL, Wang BC, Godfrey M, Sun D, Funk CD, Blendy JA. Augmented responses to morphine and cocaine in mice with a 12-lipoxygenase gene disruption. Psychopharmacology. 170: 124-31. PMID 12845410 DOI: 10.1007/S00213-003-1526-7  0.608
2001 Walters CL, Blendy JA. Different requirements for cAMP response element binding protein in positive and negative reinforcing properties of drugs of abuse. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 21: 9438-44. PMID 11717377 DOI: 10.1523/Jneurosci.21-23-09438.2001  0.612
2000 Walters CL, Aston-Jones G, Druhan JP. Expression of fos-related antigens in the nucleus accumbens during opiate withdrawal and their attenuation by a D2 dopamine receptor agonist. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 23: 307-15. PMID 10942854 DOI: 10.1016/S0893-133X(00)00113-5  0.357
2000 Druhan JP, Walters CL, Aston-Jones G. Behavioral activation induced by D(2)-like receptor stimulation during opiate withdrawal. The Journal of Pharmacology and Experimental Therapeutics. 294: 531-8. PMID 10900229  0.331
Show low-probability matches.